Immunocore Holdings (IMCR) Intangibles (2022)
Immunocore Holdings' (IMCR) quarterly Intangibles came in at $480900.6 in Q4 2022.
Immunocore Holdings (IMCR) Intangibles (2022) Analysis & Trends
Immunocore Holdings has disclosed Intangibles across 1 years of filings, most recently posting $480900.6 for Q4 2022.
- Intangibles for Q4 2022 came in at $480900.6, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $480900.6 (changed N/A YoY), and the FY2022 annual result was $480900.6, changed N/A from the prior year.
- Intangibles came in at $480900.6 for Q4 2022 at Immunocore Holdings.
- In the past five years, Intangibles ranged from a high of $480900.6 in Q4 2022 to a low of $480900.6 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 2 | Belite Bio | 55,234.00 Bn | 55,234.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,823.14 Bn | 17,823.14 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,624.50 Bn | 3,624.21 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,745.73 Bn | 1,745.73 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,540.85 Bn | 1,540.84 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.57 Bn | 105.33 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 93.46 Bn | 93.46 Bn | - | 7.73 Mn |
| 10 | Immunocore Holdings | 1.46 Bn | 616.35 Mn | 106.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 480,900.61 |